These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 7816869)

  • 1. Ethopharmacological analysis of rat behavior on the elevated plus-maze.
    Cruz AP; Frei F; Graeff FG
    Pharmacol Biochem Behav; 1994 Sep; 49(1):171-6. PubMed ID: 7816869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.
    Pellow S; Chopin P; File SE; Briley M
    J Neurosci Methods; 1985 Aug; 14(3):149-67. PubMed ID: 2864480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and pharmacological validation of the elevated plus maze constructed with transparent walls.
    Anseloni VZ; Motta V; Lima G; Brandão ML
    Braz J Med Biol Res; 1995 May; 28(5):597-601. PubMed ID: 8555981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1.
    Dal-Cól ML; Pereira LO; Rosa VP; Calixto AV; Carobrez AP; Faria MS
    Pharmacol Biochem Behav; 2003 Jan; 74(2):395-400. PubMed ID: 12479960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat.
    Cole BJ; Hillmann M; Seidelmann D; Klewer M; Jones GH
    Psychopharmacology (Berl); 1995 Sep; 121(1):118-26. PubMed ID: 8539336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
    Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation.
    Varty GB; Morgan CA; Cohen-Williams ME; Coffin VL; Carey GJ
    Neuropsychopharmacology; 2002 Sep; 27(3):357-70. PubMed ID: 12225693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
    Pellow S; File SE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):525-9. PubMed ID: 2871560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of a plus-maze to measure anxiety in the mouse.
    Lister RG
    Psychopharmacology (Berl); 1987; 92(2):180-5. PubMed ID: 3110839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of the putative anxiolytic (+/-)-1-(2,5-dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2) in rats and mice.
    Scorza MC; Reyes-Parada M; Silveira R; Viola H; Medina JH; Viana MB; Zangrossi H; Graeff FG
    Pharmacol Biochem Behav; 1996 Jun; 54(2):355-61. PubMed ID: 8743595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated zero maze: a paradigm to evaluate antianxiety effects of drugs.
    Kulkarni SK; Singh K; Bishnoi M
    Methods Find Exp Clin Pharmacol; 2007 Jun; 29(5):343-8. PubMed ID: 17805436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multiple-test study of anxiety-related behaviours in six inbred rat strains.
    Ramos A; Berton O; Mormède P; Chaouloff F
    Behav Brain Res; 1997 Apr; 85(1):57-69. PubMed ID: 9095342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium phenobarbitone reverses the anxiogenic effects of compounds acting at three different central sites.
    Johnston AL; File SE
    Neuropharmacology; 1989 Jan; 28(1):83-8. PubMed ID: 2538770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze.
    Setem J; Pinheiro AP; Motta VA; Morato S; Cruz AP
    Pharmacol Biochem Behav; 1999 Mar; 62(3):515-21. PubMed ID: 10080245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of benzodiazepine receptors located in the dorsal periaqueductal grey of rats in anxiety.
    Russo AS; Guimarães FS; De Aguiar JC; Graeff FG
    Psychopharmacology (Berl); 1993; 110(1-2):198-202. PubMed ID: 7870885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test.
    Barbalho CA; Nunes-de-Souza RL; Canto-de-Souza A
    Brain Res; 2009 Apr; 1267():65-76. PubMed ID: 19268657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze.
    Rodgers RJ; Cole JC; Aboualfa K; Stephenson LH
    Pharmacol Biochem Behav; 1995 Dec; 52(4):805-13. PubMed ID: 8587923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-dependent effects of acute caffeine on anxiety-related behavior in PVG/c, Long-Evans and Wistar rats.
    Hughes RN; Hancock NJ
    Pharmacol Biochem Behav; 2016 Jan; 140():51-61. PubMed ID: 26577750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal ethanol effects on benzodiazepine sensitivity measured by behavior on the elevated plus-maze.
    Osborn JA; Yu C; Gabriel K; Weinberg J
    Pharmacol Biochem Behav; 1998 Jul; 60(3):625-33. PubMed ID: 9678645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal analysis of the rat's behavior in the plus-maze: effect of midazolam.
    Rosa VP; Vandresen N; Calixto AV; Kovaleski DF; Faria MS
    Pharmacol Biochem Behav; 2000 Sep; 67(1):177-82. PubMed ID: 11113498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.